Spots Global Cancer Trial Database for fluciclovine f18
Every month we try and update this database with for fluciclovine f18 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer | NCT04750473 | Anatomic Stage ... Invasive Breast... Metastatic Brea... Prognostic Stag... | Computed Tomogr... Fluciclovine F1... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Emory University | |
| Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease | NCT03868020 | Metastatic Head... Metastatic Squa... | Computed Tomogr... Fluciclovine F1... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery | NCT03515577 | Recurrent Prost... | Computed Tomogr... Fluciclovine F1... Gallium Ga 68-l... Laboratory Biom... Positron Emissi... | 19 Years - | Jonsson Comprehensive Cancer Center | |
| Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes | NCT03762759 | Prostate Adenoc... | Computed Tomogr... Fluciclovine F1... Gallium Ga68-la... Positron Emissi... | 18 Years - | Emory University | |
| 18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain | NCT04462419 | Metastatic Intr... Recurrent Intra... | Dynamic Contras... Fluciclovine F1... | 18 Years - | Mayo Clinic | |
| A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) | NCT06064097 | Stage II Nasoph... Stage III Nasop... Stage IV Nasoph... | Biopsy Biospecimen Col... Chest Radiograp... Cisplatin Computed Tomogr... Echocardiograph... Electronic Heal... Fluciclovine F1... Gemcitabine Magnetic Resona... Multigated Acqu... Nivolumab Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... X-Ray Imaging | - 21 Years | National Cancer Institute (NCI) | |
| Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial | NCT06319027 | Glioblastoma, I... | Dynamic Suscept... Fluciclovine F1... Gadolinium-Chel... Magnetic Resona... Positron Emissi... | 18 Years - | Eastern Cooperative Oncology Group | |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging | NCT04423211 | Biochemically R... Metastatic Pros... Prostate Adenoc... Stage IVB Prost... | 3-Dimensional C... Apalutamide Computed Tomogr... Degarelix External Beam R... Fluciclovine F1... Goserelin Aceta... Intensity-Modul... Intensity-Modul... Leuprolide Acet... Magnetic Resona... Positron Emissi... Quality-of-Life... Questionnaire A... Relugolix Stereotactic Bo... Triptorelin Volume Modulate... | 18 Years - | Eastern Cooperative Oncology Group | |
| F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery | NCT03926507 | Glioblastoma | Computed Tomogr... Fluciclovine F1... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | NCT03349463 | Cervical Cancer Endometrial Can... Ovarian Epithel... | Fluciclovine F1... | 18 Years - | Loyola University | |
| Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone | NCT03707184 | Metastatic Pros... Prostate Carcin... Stage IV Prosta... | Computed Tomogr... Fluciclovine F1... Positron Emissi... | - | University of Utah | |
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer | NCT04134208 | Metastatic Pros... Stage IVB Prost... | Computed Tomogr... Fluciclovine F1... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
